INGRAM DOUGLAS S bought ARWR
February 6, 2025 · Form 4 insider transaction
INGRAM DOUGLAS S bought 38,396 shares of Arrowhead Pharmaceuticals, Inc. at $20.09 per share, a transaction worth $771.4K. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
38,396
Price
$20.09
Total value
$771.4K
InsiderINGRAM DOUGLAS S
RoleOfficer, Director
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateFebruary 6, 2025
Filing dateFebruary 7, 2025
Shares owned after38,396
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Represents shares underlying restricted stock units with a grant date 02/06/2025, which will vest in three years.